FindTrial
Sign In

Effects of intranasal dexmedetomidine combined with ketamine sedation for echocardiography in pediatric patients with congenitial heart disease

Effects of intranasal dexmedetomidine combined with ketamine sedation for echocardiography in pediatric patients with congenitial heart disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009780
Enrollment
Unknown
Registered
2016-11-08
Start date
2016-11-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sedation for echocardiography in pediatric patients with congenitial heart disease

Interventions

dexmedetomidine:intranasal dexmedetomidine
dexmedetomidine combined with ketamine:intranasal combined with ketamine

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1. Children with congenitial heart disease aged 0 to 3 years (ASA I or II); 2. To be scheduled to undergo echocardiography under sedation.

Exclusion criteria

Exclusion criteria: Children with history of allergy to eutectic mixture of local anesthetic (EMLA) cream, ketamine dexmedetomidine; presence of dysfunction (clinical or investigative derangements) of cardiovascular, central nervous, or hepatic system; children on chronic hepatic enzyme-inducing drugs; and mentally retarded children.

Design outcomes

Primary

MeasureTime frame
MOAAS SCORE;Ramsay SCORE;—

Countries

China

Contacts

Public ContactShengfen Tu

Children's Hospital of Chongqing Medical University

519194496@qq.com+86 13983416144

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026